.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Cipla
Fuji
Federal Trade Commission
Colorcon
Daiichi Sankyo
Healthtrust
Baxter
Moodys
Cerilliant

Generated: July 26, 2017

DrugPatentWatch Database Preview

Hq Spclt Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for HQ SPCLT PHARMA, and when can generic versions of HQ SPCLT PHARMA drugs launch?

HQ SPCLT PHARMA has seven approved drugs.

There are four US patents protecting HQ SPCLT PHARMA drugs.

There are forty patent family members on HQ SPCLT PHARMA drugs in twenty-five countries.

Summary for Applicant: Hq Spclt Pharma

Patents:4
Tradenames:10
Ingredients:7
NDAs:7
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt Pharma
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
esmolol hydrochloride
SOLUTION;INTRAVENOUS205703-001Apr 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Hq Spclt Pharma
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
esmolol hydrochloride
SOLUTION;INTRAVENOUS205703-002Apr 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
LINEZOLID
linezolid
SOLUTION;IV (INFUSION)207001-002Jul 7, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
esmolol hydrochloride
SOLUTION;INTRAVENOUS205703-002Apr 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Hq Spclt Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt Pharma
TAXOL
paclitaxel
INJECTABLE;INJECTION020262-001Dec 29, 1992► Subscribe► Subscribe
Hq Spclt Pharma
TAXOL
paclitaxel
INJECTABLE;INJECTION020262-001Dec 29, 1992► Subscribe► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 1988► Subscribe► Subscribe
Hq Spclt Pharma
TAXOL
paclitaxel
INJECTABLE;INJECTION020262-001Dec 29, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Hq Spclt Pharma Drugs

Country Document Number Estimated Expiration
China105263809► Subscribe
World Intellectual Property Organization (WIPO)2014143845► Subscribe
Turkey200202557► Subscribe
European Patent Office1368019► Subscribe
Brazil0203517► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Hq Spclt Pharma Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014 00034Denmark► SubscribePRODUCT NAME: PACLITAXEL FORMULERET SOM ALBUMINBUNDNE NANOPARTIKLER; REG. NO/DATE: C(2013)9835 20131220
0673Netherlands► SubscribePRODUCT NAME: PACLITAXEL, GEFORMULEERD ALS ALBUMINE-GEBONDEN NANODEELTJES; REGISTRATION NO/DATE: EU/1/07/428/001-002 20131220
03C/005Belgium► SubscribePRODUCT NAME: CHLORHYDRATE DE DEXMEDETOMIDINE; REGISTRATION NO/DATE: EU/2/02/033/001 20020903
/2014Austria► SubscribePRODUCT NAME: PACLITAXEL, DAS ALS ALBUMIN GEBUNDENE NANOPARTIKEL FORMUIERT IST.; REGISTRATION NO/DATE: EU/1/07/428 (MITTEILUNG) (GEAENDERT DURCH C(2013) 9835) 20131230
/2002Austria► SubscribePRODUCT NAME: LINEZOLID; NAT. REGISTRATION NO/DATE: 1-24227 - 1-24230 20011009; FIRST REGISTRATION: GB PL 00032/0259 - PL 00032/0262 20010105
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Dow
Boehringer Ingelheim
Chinese Patent Office
Cerilliant
Healthtrust
McKesson
Mallinckrodt
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot